I Srivastava

489 total citations
14 papers, 397 citations indexed

About

I Srivastava is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Immunology. According to data from OpenAlex, I Srivastava has authored 14 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 3 papers in Genetics and 3 papers in Immunology. Recurrent topics in I Srivastava's work include Malaria Research and Control (4 papers), Mosquito-borne diseases and control (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). I Srivastava is often cited by papers focused on Malaria Research and Control (4 papers), Mosquito-borne diseases and control (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). I Srivastava collaborates with scholars based in United States, Switzerland and India. I Srivastava's co-authors include Sabine Yerly, A. Rougemont, Lionel Perrin, Ying Lian, Jeffrey B. Ulmer, Carl Wild, Leonidas Stamatatos, Agegnehu Gettie, Susan Hilt and Susan W. Barnett and has published in prestigious journals such as The Lancet, The Journal of Immunology and Journal of Virology.

In The Last Decade

I Srivastava

14 papers receiving 379 citations

Peers

I Srivastava
Nancy H. McManus United States
Ariane Volkmann United States
Selma Rebus United Kingdom
Frank Ferro United States
Nancy H. McManus United States
I Srivastava
Citations per year, relative to I Srivastava I Srivastava (= 1×) peers Nancy H. McManus

Countries citing papers authored by I Srivastava

Since Specialization
Citations

This map shows the geographic impact of I Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Srivastava more than expected).

Fields of papers citing papers by I Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Srivastava. The network helps show where I Srivastava may publish in the future.

Co-authorship network of co-authors of I Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of I Srivastava. A scholar is included among the top collaborators of I Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Srivastava. I Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pande, Arun K., et al.. (2023). Addressing Challenges in Insulin Storage: An Ethical Dilemma among Physicians. Indian Journal of Endocrinology and Metabolism. 27(2). 140–144. 2 indexed citations
3.
Franti, Michael, L. M. Smith, Anders Lilja, et al.. (2009). P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes. Retrovirology. 6(S3). 1 indexed citations
4.
Bråve, Andreas, Jorma Hinkula, Aurelio Cafaro, et al.. (2007). Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge. Vaccine. 25(39-40). 6882–6890. 10 indexed citations
6.
Long, Carole A., T M Daly, Peter E. Kima, & I Srivastava. (1994). Immunity to Erythrocytic Stages of Malarial Parasites. American Journal of Tropical Medicine and Hygiene. 50(4_Suppl). 27–32. 20 indexed citations
7.
Kima, Peter E., I Srivastava, & Carole A. Long. (1992). Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection. Infection and Immunity. 60(12). 5065–5070. 8 indexed citations
8.
Srivastava, I, et al.. (1992). Identification and purification of glucose phosphate isomerase of Plasmodium falciparum. Molecular and Biochemical Parasitology. 54(2). 153–164. 15 indexed citations
9.
Srivastava, I, Michael Schmidt, Sabine Yerly, et al.. (1991). Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malaria.. PubMed. 94(3). 189–94. 1 indexed citations
10.
Yerly, Sabine, et al.. (1990). Development of a haptoglobin ELISA. Its use as an indicator for malaria. Acta Tropica. 47(4). 237–244. 12 indexed citations
11.
Srivastava, I, et al.. (1990). Specificity and inhibitory activity of antibodies to Plasmodium falciparum aldolase.. The Journal of Immunology. 144(4). 1497–1503. 22 indexed citations
12.
Rougemont, A., Lionel Perrin, Sabine Yerly, et al.. (1988). HYPOHAPTOGLOBINAEMIA AS AN EPIDEMIOLOGICAL AND CLINICAL INDICATOR FOR MALARIA. The Lancet. 332(8613). 709–712. 103 indexed citations
13.
Srivastava, I, et al.. (1988). Development of malaria vaccines.. PubMed. 40(3). S6–21. 8 indexed citations
14.
Srivastava, I, et al.. (1983). Enzyme-linked immunosorbent assay test with Plasmodium knowlesi antigen in diagnosis of malaria.. PubMed. 77. 431–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026